App is temporarily unavailable
Description
采药通，国内药品批发采购的B2B网上商城。为医药原材料公司、药企、商业公司、终端（药店、医疗机构）提供包括“药品、保健食品、医疗器械、化妆品、母婴用品、计生用品、中药材、中药饮片、药食同源等”全系列健康商品的一站式采销服务平台。
Screenshots
采药通 FAQ
-
Is 采药通 free?
Yes, 采药通 is completely free and it doesn't have any in-app purchases or subscriptions.
-
Is 采药通 legit?
Not enough reviews to make a reliable assessment. The app needs more user feedback.
Thanks for the vote -
How much does 采药通 cost?
采药通 is free.
-
What is 采药通 revenue?
To get estimated revenue of 采药通 app and other AppStore insights you can sign up to AppTail Mobile Analytics Platform.
User Rating
App is not rated in Netherlands yet.
Ratings History
采药通 Reviews
采药通 Installs
Last 30 days
采药通 Revenue
Last 30 days采药通 Revenue and Downloads
Gain valuable insights into 采药通 performance with our analytics.
Sign up now to access downloads, revenue, and more.
Sign up now to access downloads, revenue, and more.
App Info
- Category
- Shopping
- Publisher
-
陕西采药通网络科技有限公司
- Languages
- English, Chinese
- Recent release
- 3.0.125 (3 weeks ago )
- Released on
- Sep 22, 2021 (3 years ago )
- Also available in
- China , Poland , Italy , Japan , South Korea , Kuwait , Kazakhstan , Lebanon , Mexico , Malaysia , Nigeria , Netherlands , Norway , New Zealand , Peru , Philippines , Pakistan , India , Portugal , Romania , Russia , Saudi Arabia , Sweden , Singapore , Thailand , Türkiye , Taiwan , Ukraine , United States , Vietnam , South Africa , Dominican Republic , Argentina , Austria , Australia , Azerbaijan , Belgium , Brazil , Belarus , Canada , Switzerland , Chile , Colombia , Czechia , Germany , Denmark , United Arab Emirates , Algeria , Ecuador , Egypt , Spain , Finland , France , United Kingdom , Greece , Hong Kong SAR China , Hungary , Indonesia , Ireland , Israel
- Last Updated
- 3 months ago
This page includes copyrighted content from third parties, shared solely for commentary and research in accordance with fair use under applicable copyright laws. All trademarks, including product, service, and company names or logos, remain the property of their respective owners. Their use here falls under nominative fair use as outlined by trademark laws and does not suggest any affiliation with or endorsement by the trademark holders.